A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
NCT03627468
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Axillary Hyperhidrosis
Interventions
DRUG:
Sofpironium Bromide Gel, 5%
DRUG:
Sofpironium Bromide Gel, 15%
Sponsor
Botanix Pharmaceuticals